OTC · PXRB
PixarBio Corporation
Consumer Cyclical · Personal Products & Services
$0.00
Up+$0.00 (+0.00%)
Updated Aug 17, 2026, 11:01 AM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 82
- P/E ratio
- —
- Dividend yield
- —
- 52-week range
- — – —
- Volume
- 300
- Avg. volume
- 100
Price performance
PXRB price history
1M range · 0 trading sessions · Daily adjusted prices
PXRB does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest PXRB news
The latest Smart Investors Daily articles mentioning PXRB.
Stock researchCompany · Overview
PXRB research
Overview
Company profile and research snapshot.
Company profile
PixarBio Corporation, a specialty pharmaceutical/biotechnology company, focuses on the pre-clinical and clinical development of neurological drug delivery systems for post-operative pain. The company researches and develops delivery systems for drugs, devices, or biologics to treat pain, epilepsy, epilepsy, Parkinson's disease, and spinal cord injury. Its principal product platform is NeuroRelease for the therapeutic release of non-opiate drugs for post-operative, acute, and chronic pain in pre-clinical models. The company was founded in 2014 and is based in Medford, Massachusetts.
Analyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
